Linezolid Suppliers & Bulk Manufacturers
Available Forms: IV Infusion
Available Strengths: 600 mg/300 mL (2 mg/mL)
Reference Brands: Zyvox(US & EU)
Category:
Critical Care
Linezolid is a potent antibiotic for resistant infections like MRSA and VRE. Available in 600 mg tablets, oral suspension, and 600 mg/300 mL IV infusion, it is sold under brands like Zyvox and Zyvoxid. Pharma B2B platforms offer bulk Linezolid sourcing for hospitals and critical care settings.
Linezolid is available in IV Infusion
and strengths such as 600 mg/300 mL (2 mg/mL).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Linezolid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Linezolid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Linezolid is an oxazolidinone-class antibiotic used to treat multidrug-resistant Gram-positive infections, including MRSA and VRE. It is available in oral tablets (600 mg), oral suspension (100 mg/5 mL), and IV infusion (600 mg/300 mL), making it versatile for hospital and outpatient settings. In the US, Linezolid is marketed as Zyvox by Pfizer, with generic versions by Fresenius, Teva, and Hikma. In the EU, it is sold as Zyvoxid and through major generics by Sandoz, Mylan, and Accord. Pharma B2B platforms facilitate efficient bulk procurement of Linezolid for hospitals, ICUs, and infectious disease treatment centres.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing